Industrial, Manufacturing & Heavy Industry Market News

learn details of the eclinical solutions market

Industrial Market Research

Key business strategies in eClinical Solutions Market are Medidata Solutions, Inc. (U.S.) PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.), CRF Health (U.S.), DATATRAK International, Inc. (U.S.), ERT (U.S.), MaxisIT Inc. (U.S.), Bio-Optronics, Inc. (U.S.), eClinical Solutions, Inc. (U.S.), Merge Healthcare Incorporated (U.S.), and OmniComm Systems, Inc. (U.S.).

- Advertising -

Download Brochure of eClinical Solutions Market spread across 163 Pages, Profiling 13 Companies and Supported with 72 Tables and 40 Figures is now available at www.rnrmarketresearch.com/contacts…ample?rname=57734 .

The global eClinical solutions market is estimated to reach 7.61 Billion by 2022, at a CAGR of 12.4% during the forecast period (2017-2022). Adoption of novel software solutions during clinical research and rising government funding to support clinical trials are key factors fueling the growth of the market.

Global eClinical Solutions Market, by Product

  • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
  • Clinical Trial Management Systems (CTMS) 
  • Clinical Analytics Platform 
  • Randomization and Trial Supply Management (RTMS)
  • Clinical Data Integration Platform
  • Electronic Clinical Outcome Assessment (eCOA)
  • Safety Solutions
  • Electronic Trail Master Files (eTMF)
  • Regulatory Information Management Solutions (RIMS)

Geographically, North America commanded largest share of eClinical solutions market in 2016, followed by Europe.

- Advertising -

A number of factors like increasing government grants to support clinical trials, continuous product development and launch by eClinical solution vendors, growth in number of partnerships for new drug development, high prevalence of lifestyle diseases, & an increasing aging population are further stimulating demand for eClinical solutions in North America.

 eClinical Solutions Market with Top Trends, Company Profiles, Forecast and Analysis at www.rnrmarketresearch.com/contacts/57734 .

Global eClinical solutions market is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016.

In addition, the phase III clinical trials segment is expected to grow at the highest CAGR during the forecast period.

Global eClinical Solutions Market, by End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations
  • Consulting Service Companies
  • Medical Device Manufacturers
  • Hospitals
  • Academic Research Institutions

Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.), PAREXEL International Corporation (U.S.), BioClinica, Inc.

(U.S.), CRF Health (U.S.), DATATRAK International, Inc. (U.S.), ERT (U.S.), eClinical Solutions, Inc.

(U.S.), MaxisIT Inc. (U.S.), Bio-Optronics, Inc. (U.S.), Merge Healthcare Incorporated (U.S.), and OmniComm Systems, Inc.

(U.S.) are some key players operating in the global eClinical solutions market.

Report: www.rnrmarketresearch.com/contacts/?rname=57734 .

Report covers software solutions used across all phases in clinical trial process. It aims at estimating market size and future growth potential of this market across different segments such as product type, delivery mode, clinical trial phase, end user, and regions.

Report also includes an in-depth competitive analysis of key players with their company profiles, recent developments, and key market strategies.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
This email address is being protected from spambots. You need JavaScript enabled to view it.